Prognostic Significance of CD56 Antigen Expression in Patients with De Novo Non‐M3 Acute Myeloid Leukemia
Y Sun, J Wan, Q Song, C Luo, X Li… - BioMed Research …, 2021 - Wiley Online Library
Acute myeloid leukemia (AML) is a heterogeneous group of disorders with distinct
characteristics and prognoses. Although cytogenetic changes and gene mutations are …
characteristics and prognoses. Although cytogenetic changes and gene mutations are …
Prognostic Significance of CD56 Antigen Expression in Patients with De Novo Non-M3 Acute Myeloid Leukemia.
Y Sun, J Wan, Q Song, C Luo, X Li… - BioMed Research …, 2021 - search.ebscohost.com
Acute myeloid leukemia (AML) is a heterogeneous group of disorders with distinct
characteristics and prognoses. Although cytogenetic changes and gene mutations are …
characteristics and prognoses. Although cytogenetic changes and gene mutations are …
Prognostic Significance of CD56 Antigen Expression in Patients with De Novo Non-M3 Acute Myeloid Leukemia
Y Sun, J Wan, Q Song, C Luo, X Li… - BioMed research …, 2021 - pubmed.ncbi.nlm.nih.gov
Acute myeloid leukemia (AML) is a heterogeneous group of disorders with distinct
characteristics and prognoses. Although cytogenetic changes and gene mutations are …
characteristics and prognoses. Although cytogenetic changes and gene mutations are …
[PDF][PDF] Research Article Prognostic Significance of CD56 Antigen Expression in Patients with De Novo Non-M3 Acute Myeloid Leukemia
Y Sun, J Wan, Q Song, C Luo, X Li, Y Luo, X Huang… - 2021 - pdfs.semanticscholar.org
Acute myeloid leukemia (AML) is a heterogeneous group of disorders with distinct
characteristics and prognoses. Although cytogenetic changes and gene mutations are …
characteristics and prognoses. Although cytogenetic changes and gene mutations are …
Prognostic Significance of CD56 Antigen Expression in Patients with De Novo Non-M3 Acute Myeloid Leukemia.
Y Sun, J Wan, Q Song, C Luo, X Li, Y Luo… - Biomed Research …, 2021 - europepmc.org
Acute myeloid leukemia (AML) is a heterogeneous group of disorders with distinct
characteristics and prognoses. Although cytogenetic changes and gene mutations are …
characteristics and prognoses. Although cytogenetic changes and gene mutations are …
Prognostic Significance of CD56 Antigen Expression in Patients with De Novo Non-M3 Acute Myeloid Leukemia
Y Sun, J Wan, Q Song, C Luo, X Li… - BioMed Research …, 2021 - search.proquest.com
Acute myeloid leukemia (AML) is a heterogeneous group of disorders with distinct
characteristics and prognoses. Although cytogenetic changes and gene mutations are …
characteristics and prognoses. Although cytogenetic changes and gene mutations are …
[PDF][PDF] Research Article Prognostic Significance of CD56 Antigen Expression in Patients with De Novo Non-M3 Acute Myeloid Leukemia
Y Sun, J Wan, Q Song, C Luo, X Li, Y Luo, X Huang… - 2021 - scienceopen.com
Acute myeloid leukemia (AML) is a heterogeneous group of disorders with distinct
characteristics and prognoses. Although cytogenetic changes and gene mutations are …
characteristics and prognoses. Although cytogenetic changes and gene mutations are …
[HTML][HTML] Prognostic Significance of CD56 Antigen Expression in Patients with De Novo Non-M3 Acute Myeloid Leukemia
Y Sun, J Wan, Q Song, C Luo, X Li, Y Luo… - BioMed Research …, 2021 - ncbi.nlm.nih.gov
Acute myeloid leukemia (AML) is a heterogeneous group of disorders with distinct
characteristics and prognoses. Although cytogenetic changes and gene mutations are …
characteristics and prognoses. Although cytogenetic changes and gene mutations are …
Prognostic Significance of CD56 Antigen Expression in Patients with De Novo Non-M3 Acute Myeloid Leukemia.
Y Sun, J Wan, Q Song, C Luo, X Li, Y Luo… - BioMed Research …, 2021 - go.gale.com
Acute myeloid leukemia (AML) is a heterogeneous group of disorders with distinct
characteristics and prognoses. Although cytogenetic changes and gene mutations are …
characteristics and prognoses. Although cytogenetic changes and gene mutations are …